COT Meeting: 2 July 2019

Last updated:
19 June 2019
Agenda and papers for the meeting of the Committee at 10.00am on Tuesday, 2 July 2019 in Broadway House Conference Centre, Tothill St, London, SW1H 9NQ.

Agenda

1.  Apologies for absence

2.  Draft minutes of May meeting TOX/MIN/2019/03

3.  Matters arising:
        Polycyclic aromatic hydrocarbons (PAHs) TOX/2019/27
        Exposure to fumonisins TOX/2019/28
        Genotoxicity of MCPD  TOX/2019/29
        Mycotoxins TOX/2019/30
 
4.  Male reproductive toxicity of a novel feed additive, 3-nitro-oxypropanol (3-NOP): benchmark dose modelling report (Reserved Business). TOX/2019/31

5.  Scoping paper on the potential adverse effects of CBD products. TOX/2019/32

6.  Additional data regarding Fusarenon-X in the diet of infants aged 0 to 12 months and children aged 1 to 5 years. TOX/2019/33

7.  Review of physiologically-based pharmacokinetic (PBPK) modelling used for human health risk assessment. TOX/2019/34

8.  Scoping paper on the synthesis and integration of epidemiological and toxicological evidence in risk assessments. TOX/2019/35

9.  Discussion paper on potential risks from various sweeteners in the diet of infants aged 0 to 12 months and children aged 1 to 5 years. TOX/2019/36

10. Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes):
      a) Decision tree for risk assessing flavouring compounds in E(N)NDS TOX/2019/37
      b) Toxicological review of nicotine TOX/2019/38
      c) User exposure TOX/2019/39 

11. Update paper for information: FSA Scientific Advisory Committees (SACs) update. TOX/2019/40

12. Any other business

  Date of next meeting Tuesday 17th September 2019 at Broadway House Conference Centre, Tothill St, London, SW1H 9NQ.   

Draft Minutes